Loading stock data...

Coral Laboratories Limited

BSE: CORALAB

BSE
437.00 6.30 (1.46%)

Prev Close

430.7

Open Price

436.25

Volume

98

Today Low / High

431 / 437

52 WK Low / High

415 / 805

Range

415 - 459

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 437, reflecting a change of 6.3 (1.46274%). The expected target range on the BSE is 415 - 459. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

25 Feb 436.25 0.17%
24 Feb 422.00 2.06%
23 Feb 437.80 -2.36%
20 Feb 435.60 -1.79%
19 Feb 423.00 4.52%
18 Feb 422.60 1.70%
17 Feb 426.15 0.62%
16 Feb 484.00 -11.95%
13 Feb 488.00 0.27%
12 Feb 489.30 -0.52%
11 Feb 486.00 0.70%
10 Feb 473.60 0.93%
09 Feb 468.60 0.47%
06 Feb 452.35 0.66%
05 Feb 472.95 -4.36%
04 Feb 476.60 -6.54%
03 Feb 464.95 -1.90%
02 Feb 436.60 6.50%
01 Feb 460.00 -3.12%
30 Jan 430.20 1.03%
29 Jan 432.60 -0.01%
28 Jan 435.00 1.40%

Coral Laboratories Limited Graph

Coral Laboratories Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Coral Laboratories Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 437.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 437.00 441.37 397.23 - 485.51
445.74 356.59 - 534.89
450.11 315.08 - 585.14
Bearish Scenario 437.00 432.63 389.37 - 475.89
428.26 342.61 - 513.91
423.89 296.72 - 551.06

Overview of Coral Laboratories Limited

ISIN

INE683E01017

Industry

Medical - Pharmaceuticals

Vol.Avg

1,804

Market Cap

1,561,226,200

Last Dividend

1.5

Official Website

Visit Website

IPO Date

2001-12-31

DCF Diff

-118.44

DCF

549

Financial Ratios Every Investor Needs

Stock Dividend of CORALAB

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-09-19 September 19, 25 1.5 1.5 2025-09-19 2025-10-26
2024-09-20 September 20, 24 2 2 2024-09-20 2024-10-27
2019-09-19 September 19, 19 2 2 2019-09-20 2019-10-27
2018-09-18 September 18, 18 2 2 2018-09-20 2018-10-27
2017-09-11 September 11, 17 5 5 2017-09-12 2017-10-19

Stock Rating Details for CORALAB

Metric Value Recommendation
Overall Rating C Sell
DCF Score 4 Buy
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 3 Neutral
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 115.01 Cr 69.77 Cr 45.24 Cr 0.3934 0.00 Cr 14.74 Cr 24.23 Cr 24.16 Cr 67.62 34.58 Cr 0.2100
2024-03-31 82.10 Cr 40.35 Cr 41.75 Cr 0.5086 0.00 Cr 4.02 Cr 14.26 Cr 15.79 Cr 44.19 22.71 Cr 0.1923
2023-03-31 77.89 Cr 49.26 Cr 28.63 Cr 0.3676 0.00 Cr 1.74 Cr 1.63 Cr 6.45 Cr 18.04 10.74 Cr 0.0827
2022-03-31 73.22 Cr 42.64 Cr 30.58 Cr 0.4176 0.00 Cr 2.56 Cr 6.22 Cr 9.05 Cr 25.32 13.99 Cr 0.1235
2021-03-31 95.21 Cr 53.74 Cr 41.47 Cr 0.4356 0.00 Cr 3.61 Cr 13.87 Cr 13.55 Cr 37.94 19.86 Cr 0.1424

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 3.41 Cr 229.46 Cr 28.26 Cr 201.2058 Cr 3.56 Cr 0.15 Cr 9.87 Cr 24.23 Cr 0.00 Cr 0.00 Cr 27.90 Cr 24.9575 Cr
2024-03-31 2.07 Cr 205.68 Cr 28.18 Cr 177.4966 Cr 0.00 Cr -2.07 Cr 15.16 Cr 23.27 Cr 0.00 Cr 0.00 Cr 27.43 Cr 24.8992 Cr
2023-03-31 6.13 Cr 174.35 Cr 19.55 Cr 154.7981 Cr 0.00 Cr -6.13 Cr 12.50 Cr 24.28 Cr 0.00 Cr 0.00 Cr 18.72 Cr 11.8603 Cr
2022-03-31 2.51 Cr 189.90 Cr 33.84 Cr 156.0531 Cr 6.04 Cr 3.53 Cr 18.36 Cr 24.49 Cr 0.00 Cr 0.00 Cr 2.67 Cr 25.5176 Cr
2021-03-31 2.32 Cr 167.54 Cr 30.90 Cr 136.6433 Cr 6.25 Cr 3.93 Cr 21.67 Cr 20.91 Cr 0.00 Cr 0.00 Cr -4.99 Cr 27.5647 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -1.2223 Cr -0.1520 Cr 2.7083 Cr -4.1673 Cr 1.3340 Cr 3.4054 Cr -2.9450 Cr 24.1556 Cr 3.5204 Cr -0.7145 Cr 5.2855 Cr
2024-03-31 23.0389 Cr 1.3991 Cr 0.0066 Cr 22.0479 Cr -4.0590 Cr 2.0714 Cr -0.9910 Cr 15.7890 Cr 0.0068 Cr 0.0000 Cr -2.6529 Cr
2023-03-31 12.6652 Cr -2.6147 Cr -6.4261 Cr 10.7198 Cr 3.6244 Cr 6.1304 Cr -1.9454 Cr 8.1880 Cr -6.0876 Cr 0.0000 Cr 5.8584 Cr
2022-03-31 6.0837 Cr -6.0513 Cr 0.1491 Cr 0.5354 Cr 0.1815 Cr 2.5060 Cr -5.5483 Cr 10.8963 Cr 0.2903 Cr 0.0000 Cr 3.3126 Cr
2021-03-31 0.9309 Cr -0.0681 Cr 0.3500 Cr -0.4293 Cr 1.2128 Cr 2.3245 Cr -1.3602 Cr 17.5937 Cr 0.3417 Cr 0.0000 Cr -2.3762 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 21.56 Cr 13.77 Cr 7.79 Cr 0.3614 1.20 Cr 2.78 Cr 7.77 1.89 Cr 0.1287
2025-09-30 19.03 Cr 7.55 Cr 11.48 Cr 0.6033 4.49 Cr 5.82 Cr 16.29 7.97 Cr 0.3058
2025-06-30 18.82 Cr 8.74 Cr 10.08 Cr 0.5358 1.73 Cr 2.56 Cr 7.18 4.23 Cr 0.1362
2025-03-31 28.13 Cr 14.57 Cr 13.56 Cr 0.4821 2.18 Cr 2.83 Cr 7.91 4.40 Cr 0.1005
2024-12-31 22.99 Cr 9.47 Cr 13.52 Cr 0.5882 5.81 Cr 6.14 Cr 17.20 8.84 Cr 0.2673

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 1.33 Cr 100.99 Cr 102.32 Cr 26.64 Cr 12.08 Cr 164.37 Cr 36.63 Cr 232.87 Cr 19.78 Cr
2025-06-30 0.00 Cr 0.00 Cr 107.41 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -201.21 Cr
2025-03-31 3.41 Cr 27.54 Cr 30.95 Cr 33.88 Cr 9.87 Cr 176.55 Cr 24.23 Cr 229.46 Cr 28.26 Cr
2024-12-31 0.00 Cr 0.00 Cr 91.26 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -203.55 Cr
2024-09-30 0.97 Cr 27.09 Cr 91.26 Cr 39.20 Cr 12.96 Cr 169.04 Cr 22.43 Cr 231.61 Cr 28.06 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 2.56 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 2.83 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 6.14 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 6.38 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 8.80 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹841.40 ₹100,970,844,773.00 ₹78,530.00

Key Executives

Whole-Time Director
Girish Madanlal Dhameja

Gender: male

Year Born: 1981

Company Secretary & Compliance Officer
Dhwani Desai

Gender: female

Year Born:

Chief Financial Officer & Non-Executive Director
Sushma Shashi Kadkade

Gender: female

Year Born: 1981

FAQs about Coral Laboratories Limited

Who is the CEO of the company?

The CEO is Girish Madanlal Dhameja.

What is the current market price of the stock?

The current price is ₹437.00.

What is the 52-week price range?

The range is ₹415-805.

What is the market capitalization of the company?

The market capitalization is ₹156.12 crores.

What is the dividend yield?

The dividend yield is 0.34%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 11.16.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Coral Laboratories Limited (ISIN: INE683E01017) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹156.12 crores and an average daily volume of 1,804 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹1.5.